Clinical Genomics Platform Architecture
The systems that carry a genomic result from the sequencer to the chart.
I am Steve Ayers — PhD geneticist, CISSP, CCSP, PMP. Eleven years at Stanford Health Care building and running the platforms behind clinical genomics, molecular pathology, cytogenetics, and pharmacogenomics.
What I write about
One beat: the seam between the laboratory and enterprise IT — where molecular science, regulated clinical operations, and infrastructure have to agree on the same data model, and usually do not.
Instrument to EHR
Why genomic results still arrive as PDFs, and what it actually takes to land them in Epic as discrete, queryable variant data.
Regulated cloud
Running genomic pipelines on GCP inside a CAP-inspected, HIPAA-bound clinical environment — without the compliance theater.
Vendors and cutoffs
Build-vs-buy, MSA and BAA negotiation, and migrating interpretation platforms when the vendor sets the deadline and the lab cannot go dark.
Latest writing
-
Why Genomic Results Still Land in Epic as a PDF
A physician ordering a 500-gene panel expects the result to behave like every other lab value in Epic: discrete, filterable, plottable over time. Instead it arrives as a nine-page PDF…
-
The Critical Path for Clinical Genomics: Balancing Innovation and Security
The transition of genomic science from research laboratories into routine clinical workflows is accelerating. As we generate and integrate multi-omic datasets into everyday patient care, we must ensure our informatics…
-
Securing the Genomic Revolution: Where NGS Innovation Meets Healthcare Data Security
The landscape of clinical genomics is evolving at a breakneck pace, but as we push the boundaries of Next-Generation Sequencing (NGS) and precision medicine, we are simultaneously navigating one of…
-
The Unplugged AI: Could Local LLMs Avert the Coming Datacenter Crisis?
A silent revolution is brewing on our desktops and laptops, one that could have a profound impact on the future of artificial intelligence and the very infrastructure of the internet.…
-
Addressing the Looming Crisis in Clinical Diagnostics: A Call for Strategic Investment
Once in a while, it’s good to step back from the daily grind of lab operations, EMR integrations, and security reviews to reflect on the fundamental infrastructure that underpins modern…
-
Unraveling the Potential: Incretin Mimetics in the Context of Public Health
As we traverse the broader terrain of biomedical science, the recently emerging class of drugs, called incretin mimetics, stands out with a potential to significantly influence public health, particularly in…
Working on something at this seam?
I am currently exploring roles in clinical genomics systems, clinical informatics, and healthcare IT security.
Get in touch